Evidence map›Paper›PMID 33665340›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2021

Uniform data set language measures for bvFTD and PPA diagnosis and monitoring.

Adam M Staffaroni, Sandra Weintraub, Katya Rascovsky, Katherine P Rankin, Jack Taylor, Julie A Fields, Kaitlin B Casaletto, Argye E Hillis, Sladjana Lukic, Maria Luisa Gorno-Tempini and 8 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Evaluation of Differential Diagnostics Potential of Uniform Data Set 2 Neuropsychology Battery Using Alzheimer's Disease Biomarkers.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A syntax-lexicon trade-off in language production.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Article
  16. Task performance to discriminate among variants of primary progressive aphasia.Cortex; a journal devoted to the study of the nervous system and behavior · 2021
    Article
  17. Uniform data set language measures for bvFTD and PPA diagnosis and monitoring.Alzheimer's & dementia (Amsterdam, Netherlands) · 2021
    Article
  18. Article
  19. Article
  20. Alzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Adam M StaffaroniDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Sandra WeintraubMesulam Center for Cognitive Neurology and Alzheimer's Disease and Department of Psychiatry and Behavioral Sciences Feinberg School of Medicine Department of Neurology Northwestern University Chicago Illinois USA.
Katya RascovskyPenn Frontotemporal Degeneration Center Department of Neurology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
Katherine P RankinDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Jack TaylorDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Julie A FieldsDepartment of Psychiatry and Psychology Mayo Clinic Division of Neurocognitive Disorders Rochester Minnesota USA.
Kaitlin B CasalettoDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Argye E HillisDepartment of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USA.
Sladjana LukicDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Maria Luisa Gorno-TempiniDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Hilary HeuerDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Merilee A TeylanNational Alzheimer's Coordinating Center Department of Epidemiology University of Washington Seattle Washington USA.
Walter A KukullNational Alzheimer's Coordinating Center Department of Epidemiology University of Washington Seattle Washington USA.
Bruce L MillerDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Bradley F BoeveDepartment of Neurology College of Medicine Mayo Clinic Rochester Minnesota USA.
Howard J RosenDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Adam L BoxerDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
Joel H KramerDepartment of Neurology Memory and Aging Center Weill Institute for Neurosciences University of California at San Francisco (UCSF) San Francisco California USA.
University Memory and Aging Center · USUniversity of California, San Francisco · USUniversity of Washington · USJohns Hopkins University · USMayo Clinic · USMayo Clinic in Florida · USNorthwestern University · USUniversity of Pennsylvania · US

Funding

Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI John Kornak · 2019 to 2026
$120.9M
NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI BRUCE L MILLER · 2002 to 2026
$67.2M
THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI BUCHWALD, DEDRA S · 1985 to 2019
$57.2M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
Satellite Diagnostic and Treatment Clinic CoreP50AG008702 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DE JAGER, PHILIP L · 1989 to 2019
$46.3M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 1985 to 2019
$43.0M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRASKIE, MEREDITH NICOLE · 1985 to 2019
$41.0M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SEWELL, MARGARET · 1985 to 2019
$37.9M
'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI TRONCOSO, JUAN · 1985 to 2019
$37.6M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI FOROUD, TATIANA M. · 1991 to 2020
$37.3M
NIA NIH HHS K23 AG058752NIA NIH HHS K23 AG061253NIA NIH HHS K24 AG045333NIA NIH HHS P01 AG017586NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG008017NIA NIH HHS P30 AG008051NIA NIH HHS P30 AG010124NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG010133NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG012300NIA NIH HHS P30 AG013846NIA NIH HHS P30 AG013854NIA NIH HHS P30 AG019610NIA NIH HHS P30 AG028383NIA NIH HHS P30 AG035982NIA NIH HHS P30 AG049638NIA NIH HHS P30 AG053760NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG062422NIA NIH HHS P30 AG062428NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG066444NIA NIH HHS P30 AG066507NIA NIH HHS P50 AG005133NIA NIH HHS P50 AG005136NIA NIH HHS P50 AG005138NIA NIH HHS P50 AG005142NIA NIH HHS P50 AG005146NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG008702NIA NIH HHS P50 AG016573NIA NIH HHS P50 AG023501NIA NIH HHS P50 AG025688NIA NIH HHS P50 AG047266NIA NIH HHS P50 AG047270NIA NIH HHS P50 AG047366NIA NIH HHS R01 AG032306NIA NIH HHS R01 AG054519NIA NIH HHS U01 AG016976NIA NIH HHS U01 AG045390NIA NIH HHS U19 AG063911NIDCD NIH HHS K24 DC015544NINDS NIH HHS R01 NS050915NINDS NIH HHS U54 NS092089
6 · The paper itself

Abstract

introductionThe Frontotemporal Lobar Degeneration Module (FTLD-MOD) includes a neuropsychological battery designed to assess the clinical features of FTLD, although much is unknown about its utility. We investigated FTLD-MOD and Uniform Data Set 3.0 (UDS) language tests for differential diagnosis and disease monitoring.

methodsLinear regressions compared baseline performances in 1655 National Alzheimer's Coordinating Center participants (behavioral variant frontotemporal dementia (bvFTD, n = 612), semantic variant primary progressive aphasia (svPPA, n = 168), non-fluent/agrammatic variant PPA (nfvPPA, n = 168), logopenic variant PPA (lvPPA, n = 109), and controls (n = 581)). Sample sizes to detect treatment effects were estimated using longitudinal data.

resultsAmong PPAs, the FTLD-MOD language tasks and UDS Multilingual Naming Test accurately discriminated svPPA. Number Span Forward best discriminated lvPPA; Phonemic:Semantic Fluency ratio was excellent for nfvPPA classification. UDS fluency and naming measures required the smallest sample size to detect meaningful change. DISCUSSION: The FTLD-MOD and UDS differentiated among PPA subtypes. UDS 3.0 measures performed best for longitudinal monitoring.

Indexed as

clinical trialscognitiondifferential diagnosisendpointsfrontotemporal dementia (FTD)FTLD modulelongitudinalneuropsychologyprimary progressive aphasia (PPA)speech

Identifiers

PMID33665340
PMCPMC7896637
OpenAlexW3131330772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.